Exozymes Inc. 8-K Filing

Ticker: EXOZ · Form: 8-K · Filed: Mar 31, 2026 · CIK: 0002010788

Exozymes Inc. 8-K Filing Summary
FieldDetail
CompanyExozymes Inc. (EXOZ)
Form Type8-K
Filed DateMar 31, 2026
Pages1
Reading Time2 min
Sentimentneutral

Sentiment: neutral

FAQ

What type of filing is this?

This is a 8-K filing submitted by Exozymes Inc. (ticker: EXOZ) to the SEC on Mar 31, 2026.

How long is this filing?

Exozymes Inc.'s 8-K filing is 1 pages with approximately 393 words. Estimated reading time is 2 minutes.

Where can I view the full 8-K filing?

The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.

Filing Stats: 393 words · 2 min read · ~1 pages · Grade level 10.2 · Accepted 2026-03-31 06:12:00

Filing Documents

01 — Other Events

Item 8.01 — Other Events. Attached is an updated Investor Presentation of eXoZymes Inc., a Nevada corporation, as of March 30, 2026, in connection with its NCTx business.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibits Description of Exhibit 99.1 Investor Presentation of eXoZymes Inc. for NCTx as of March 30, 2026. 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 30, 2026 EXOZYMES INC. By /s/ Fouad Nawaz Fouad Nawaz, Vice President, Finance

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.